Indigenous communities at risk of antimicrobial resistance

0
Pharmacists say a new approach is needed to treat the high rates of bacterial infections among remote Indigenous communities after a new study suggested...

How psilocybin can help terminally ill patients

0
Psilocybin, a psychoactive compound found in ‘magic mushrooms’, is being trialled in the treatment of terminally ill patients to reduce symptoms of depression and...

Research winners for PSA18

0
Researchers examining polypharmacy within aged populations have won the best paper and best poster categories at PSA18. Lauren Corre and a team of University of...

Emily Griffin keynote address to the Medication Safety and Efficiency Conference

0
PSA Victorian Early Career Pharmacist of the Year Emily Griffin's keynote address to the Medication Safety and Efficiency Conference.

SSRIs for mild cognitive impairment to Alzheimer’s disease

Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment? An estimated 10% of people...

Medicine safety in aged care must be improved

0
One in five unplanned hospital admissions for aged care residents is the result of inappropriate medicines use, a new report from PSA reveals.